126 related articles for article (PubMed ID: 23989444)
1. 111In-pentetreotide uptake in an ovarian teratoma and impact of SPECT/CT imaging.
Sainz-Esteban A; González ML; Vara-Castrodeza A; García-Talavera P; Olmos R; Ángeles Ruiz M; Gamazo C; Gómez A
Clin Nucl Med; 2013 Oct; 38(10):843-5. PubMed ID: 23989444
[TBL] [Abstract][Full Text] [Related]
2. Synchronous ileocecal neuroendocrine tumor and carotid chemodectoma: diagnosis by 111In pentetreotide SPECT/CT.
Wisotzki C; Jacobsen F; Salamon J; Derlin T
Clin Nucl Med; 2014 Jun; 39(6):547-8. PubMed ID: 24097001
[TBL] [Abstract][Full Text] [Related]
3. Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
Sainz-Esteban A; Olmos R; González-Sagrado M; González ML; Ruiz MÁ; García-Talavera P; Gamazo C; Villanueva JG; Cobo A; de Luis D
Nucl Med Commun; 2015 Mar; 36(3):251-9. PubMed ID: 25369750
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine uptake in an ovarian mature teratoma detected with SPECT/CT.
Yazici B; Oral A; Omur O; Yazici A
Clin Nucl Med; 2015 Feb; 40(2):e157-60. PubMed ID: 25140551
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of gallium-67 within mature and immature teratoma in pediatric patients: investigation for the uptake mechanism.
Kunieda E; Hara H; Morikawa Y; Hirobe S; Kamagata S; Kubo A
Ann Nucl Med; 2008 Apr; 22(3):207-13. PubMed ID: 18498036
[TBL] [Abstract][Full Text] [Related]
6. Indium-111-pentetreotide imaging in intra-axial brain tumors: comparison with thallium-201 SPECT and MRI.
Lee JD; Kim DI; Lee JT; Chang JW; Park CY
J Nucl Med; 1995 Apr; 36(4):537-41. PubMed ID: 7699438
[TBL] [Abstract][Full Text] [Related]
7. Comparison of single time-point [111-In] pentetreotide SPECT/CT with dual time-point imaging of neuroendocrine tumors.
Wong KK; Wynn EA; Myles J; Ackermann RJ; Frey KA; Avram AM
Clin Nucl Med; 2011 Jan; 36(1):25-31. PubMed ID: 21157203
[TBL] [Abstract][Full Text] [Related]
8. Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids.
Schillaci O; Scopinaro F; Danieli R; Angeletti S; Tavolaro R; Annibale B; Cannas P; Marignani M; Colella AC; Delle Fave G
Anticancer Res; 1997; 17(3B):1753-6. PubMed ID: 9179229
[TBL] [Abstract][Full Text] [Related]
9. Whole body and tomographic scan with 111In-pentetreotide: preliminary data.
Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769
[TBL] [Abstract][Full Text] [Related]
10. Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors.
Wong KK; Cahill JM; Frey KA; Avram AM
Acad Radiol; 2010 Mar; 17(3):291-7. PubMed ID: 19962915
[TBL] [Abstract][Full Text] [Related]
11. 111In-Pentetreotide SPECT/CT in Pulmonary Carcinoid.
Chiaravalloti A; Spanu A; Danieli R; Dore F; Piras B; Falchi A; Tavolozza M; Madeddu G; Schillaci O
Anticancer Res; 2015 Jul; 35(7):4265-70. PubMed ID: 26124388
[TBL] [Abstract][Full Text] [Related]
12. CT images of a malignant-transformed ovarian mature cystic teratoma with rupture: a case report.
Wang PC; Yang TL; Pan HB
Korean J Radiol; 2008; 9(5):458-61. PubMed ID: 18838856
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of an ovarian mature cystic teratoma: computed tomography findings.
Lai PF; Hsieh SC; Chien JC; Fang CL; Chan WP; Yu C
Arch Gynecol Obstet; 2005 Apr; 271(4):355-7. PubMed ID: 15551144
[TBL] [Abstract][Full Text] [Related]
14. An unusual muscular metastasis in a patient affected by ileal carcinoid imaged with a ¹¹¹In-Pentetreotide SPECT/CT scan and confirmed by biopsy.
Caobelli F; Bertagna F; Panarotto MB; Paghera B; Giubbini R
Clin Nucl Med; 2011 Aug; 36(8):696-7. PubMed ID: 21716024
[TBL] [Abstract][Full Text] [Related]
15. Incidental scintigraphic finding of ovarian teratoma containing normal thyroid tissue on post-radioactive iodine therapy for papillary thyroid cancer.
Gauthé M; Kelly A; Dejax C; Cachin F; Bourdel N
Clin Nucl Med; 2013 Jun; 38(6):467-8. PubMed ID: 23531739
[TBL] [Abstract][Full Text] [Related]
16. Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.
Balink H; Apperloo MJ; Collins J
Clin Nucl Med; 2012 Aug; 37(8):804-6. PubMed ID: 22785518
[TBL] [Abstract][Full Text] [Related]
17. In situ radiotherapy with 111In-pentetreotide: initial observations and future directions.
McCarthy KE; Woltering EA; Espenan GD; Cronin M; Maloney TJ; Anthony LB
Cancer J Sci Am; 1998; 4(2):94-102. PubMed ID: 9532411
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal rupture of a benign cystic ovarian teratoma: findings at CT and MR imaging.
Fibus TF
AJR Am J Roentgenol; 2000 Jan; 174(1):261-2. PubMed ID: 10628494
[No Abstract] [Full Text] [Related]
19. 111In-pentetreotide (somatostatin analogue) scintigraphy as an imaging procedure for endocrine gastro-entero-pancreatic tumors.
Nauck C; Ivancević V; Emrich D; Creutzfeldt W
Z Gastroenterol; 1994 Jun; 32(6):323-7. PubMed ID: 7975760
[TBL] [Abstract][Full Text] [Related]
20. Reconstruction parameters for 111In-pentetreotide SPECT: variability with respect to body weight and body region.
Massaro A; Cittadin S; Rossi F; Rampin L; Banti E; Nibale O; Rubello D
J Nucl Med Technol; 2007 Dec; 35(4):237-41. PubMed ID: 18006596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
